How many insider trades does FilingIQ track for IMA?

FilingIQ tracks 24 Form 4 insider transactions for IMA (ImageneBio, Inc.), covering filings from Jul 25, 2025 onwards. 6 of those were filed in the last 90 days.

Are IMA insiders net buyers or net sellers?

Across the full Form 4 history for IMA, 7 transactions (29%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does IMA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is IMA in?

ImageneBio, Inc. (IMA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $65.13M.

IMA insider trading

NasdaqCM Healthcare

ImageneBio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

29% / 0%

Market cap

$65.13M

About ImageneBio, Inc.

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Company website: www.inmagenebio.com

IMA insider activity at a glance

FilingIQ has scored 24 insider transactions for IMA since Jul 25, 2025. The most recent filing in our index is dated Apr 14, 2026.

Across the full history, 7 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IMA insider trades is 64.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live IMA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for IMA?: FilingIQ tracks 24 Form 4 insider transactions for IMA (ImageneBio, Inc.), covering filings from Jul 25, 2025 onwards. 6 of those were filed in the last 90 days.
Are IMA insiders net buyers or net sellers?: Across the full Form 4 history for IMA, 7 transactions (29%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IMA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is IMA in?: ImageneBio, Inc. (IMA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $65.13M.

Methodology & sources

Every IMA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.